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Abstract
A chromatographic immunoassay is a technique in which an antibody or
antibodyrelated agent is used as part of a chromatographic system for
the isolation or measurement of a specific target. Various binding agents,
detection methods, supports and assay formats have been developed for
this group of methods, and applications have been reported that range
from drugs, hormones and herbicides to peptides, proteins and bacteria. This review discusses the general principles and applications of chromatographic immunoassays, with an emphasis being given to methods
and formats that have been developed for the analysis of drugs and biological agents. The relative advantages or limitations of each format
are discussed. Recent developments and research in this field, as well as
possible future directions, are also considered.
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Key terms
Chromatographic immunoassay: A technique in which an antibody or antibodyrelated agent is attached to a support and used as part of a chromatographic
system for the isolation or measurement of a specific target; also known as
an immunochromatographic assay, a flow immunoassay or a flow-injection
immunoassay.
Direct detection chromatographic immunoassay: A chromatographic immunoassay that is used for direct detection of a target.
Immunoextraction: The use of immobilized antibodies to isolate a given target
prior to its analysis or measurement by a second method.
Simultaneous injection method: A type of competitive binding chromatographic
immunoassay in which a sample is mixed with a fixed amount of the label and
applied together to a column containing a limited amount of an immobilized
antibody or related binding agent for the target.
Sequential injection method: A type of competitive binding chromatographic immunoassay in which the sample is applied first to a column containing an immobilized antibody or related binding agent, followed later by application of
the label.
Displacement immunoassay: A type of chromatographic immunoassay in which
a target displaces a label from a column containing an immobilized antibody or
related binding agent.
One-site immunometric assay: A type of chromatographic immunoassay in which
a sample containing the target is incubated with an excess of labeled antibodies (or related binding agents) that can bind to this target, followed by injection of this mixture onto a column that contains an immobilized analog of the
target.
Chromatographic sandwich immunoassay: A type of chromatographic immunoassay that employs two types of antibodies or binding agents that can bind simultaneously to the same target; one type of binding agent is immobilized to
a support, and the second binding agent is labeled and mixed with the sample
before these components are applied to the column or applied to the column
after the sample has been injected.

The analysis of drugs and biological compounds is an essential
component in clinical chemistry, therapeutic drug monitoring, proteomics and the screening or development of new pharmaceutical
agents [1,2]. Common challenges that are often faced in these fields
are the complexity of the samples that are being examined and the
low concentrations of the desired compounds that must be measured. One way to overcome these challenges is to utilize immunoassays, which can often provide sensitive and specific measurements
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for drugs and other compounds in complex samples [1–5]. An immunoassay can be defined as an analytical technique that utilizes antibodies or antibody-related agents to selectively bind a given target
compound [3–5]. Antibodies are glycoproteins that are produced by
the immune system in response to a foreign agent, or antigen [2,3].
Antibodies can be generated against a wide range of compounds and
can have both specific and strong binding, with many antibody–target
interactions having association equilibrium constants in the range of
105 to 1012 M-1. These interactions are reversible and usually involve a
combination of steric effects and noncovalent forces such as dipolerelated interactions, ionic forces, nonpolar interactions and hydrogen
bonding [6].
Antibodies have been used in many formats to carry out immunoassays. One method that has been of interest in recent years is a
chromatographic immunoassay or immunochromatographic assay
(also sometimes called a ‘flow immunoassay’ or ‘flowinjection immunoassay’) [5–13]. In this technique, an antibody or antibody-related
agent (e.g., an antibody fragment) is attached to a chromatographic
support or used as part of a chromatographic system for the isolation or measurement of a specific target. A simple example of such a
method is shown in Figure 1 [14]. Various binding agents, detection
methods, supports and assay formats have been reported for this
group of methods. In addition, this set of techniques has been used
in applications ranging from low mass compounds such as drugs, hormones and herbicides to higher mass targets such as peptides, proteins and bacteria [6–14].
This review will discuss the general principles, components and
applications of chromatographic immunoassays. Particular emphasis
will be given to methods that have been developed for the analysis of
drugs and biological agents. This discussion will include an overview
of the types of binding agents, detection methods, supports and elution conditions that can be used in this approach. This will be followed
by a description of the various measurement formats that have been
reported for chromatographic immunoassays. Representative applications for each format will be presented, and the relative advantages
or limitations of each format will be examined. Recent developments
and research in this field, as well as possible future directions in this
area, will also be considered.
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General components of chromatographic immunoassays
Antibodies & related binding agents
The antibody or binding agent that is used in a chromatographic
immunoassay is usually the key factor in determining the specificity for this type of method [6,7]. A typical IgG class antibody, as used
within the scheme shown in Figure 1A, has a ‘Y’-shaped structure
that is composed of four polypeptide chains (i.e., two identical sets
of heavy and light chains) which are linked by disulfide bonds [3,6].
The Fc region (i.e., the ‘crystallizable fragment’ or ‘constant region’) is
located in the lower stem region of this structure and is highly conserved from one antibody to the next in the same class. Two identical Fab regions (or ‘antigen binding’ regions) are found in the upper
portion of the antibody and contain the sites at which a given target,
or ‘antigen,’ can bind to the antibody. A change in the amino acid sequence within the Fab regions from one type of antibody to the next
is what makes it possible for the body to produce antibodies against
a wide variety of foreign agents [6,8].
Many chromatographic immunoassays utilize intact polyclonal antibodies or monoclonal antibodies. Polyclonal antibodies are the typical antibodies that are produced by the immune system. This type of
preparation often consists of a heterogeneous population of antibodies with a range of affinities and binding regions on a particular antigen or target. This type of antibody is often used when strong binding is required in an immunoassay and when some cross-reactivity of
the antibodies with agents that are closely related to the target is either desired or acceptable [6,7]. Monoclonal antibodies are produced
from single hybrid cell lines, or ‘hybridomas,’ and are used when antibodies with a high level of specificity and good batch-to-batch reproducibility are needed [6–8]. Other types of antibodies that have
been used occasionally in chromatographic immunoassays are autoantibodies, which are naturally occurring antibodies produced against
components of the original host, and anti-idiotypic antibodies, which
bind to receptors or their substrates in the body [6]. In addition, antibody fragments, such as those consisting of the Fab portion of an antibody, can be used as binding agents in some types of chromatographic immunoassays [6,7].
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Figure 1. Direct detection format for a chromatographic immunoassay. (A) General
scheme for a chromatographic immunoassay with direct detection of its target(s)
and (B) use of a low-performance 150 mm × 10.0 mm id antibody column for the
immunoextraction of d-methamphetamine and related compounds from urine, followed by analysis of these extracted solutes by GC–MS. The fractions in (B) each a
volume of 0.6 ml and were collected at 0.4 ml/min; the contents of these fractions
were then derivatized with trichloroanhydride and placed into ethyl acetate prior
to injection onto a GC–MS system. The results in (B) are for the analysis of normal
urine (circles) or urine (triangles) from a methamphetamine addict; the inset shows
the pH gradient that was used for elution of the retained target from the antibody
column. (B) Adapted with permission from [14].
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There has been additional work involving the use of genetically
engineered antibodies or antibody-like molecules in chromatographic immunoassays [6]. The use of these binding agents can provide greater versatility than traditional antibodies in the categories
of compounds that can be analyzed by a chromatographic immunoassay and may even lead to an improvement in the binding strength
and specificity for a target [6,15]. In some cases, these agents can be
created to be ‘bifunctional’ or ‘bispecific,’ which allows their interaction with two different antigens or targets at the same time [6]. A few
studies have also explored the use of recombinant single-chain antibody fragments for use in the chromatographic purification of proteins from cell cultures and cell lysates [6,16].
Aptamers have been used as ‘antibody mimics’ or alternatives to
antibodies in some chromatographic binding assays [17–20]. These
binding agents consist of single-stranded DNA or RNA sequences
that are often 10 to 100 nucleotides in length and that have the ability to form highly ordered 3D structures [19]. Aptamers are prepared
through a selection and amplification process known as SELEX (i.e., the
‘systematic evolution of ligands by exponential enrichment’), which
can be used to generate specific binding agents with relatively high
affinities for a particular target [17,18]. These agents have been used
to bind targets that have included drugs, peptides, proteins and cells
[17–20]. It is possible to easily modify the structure of an aptamer to
include a label or to immobilize the aptamer to a support [18,19]. In
addition to being used in biosensors [17,18], aptamers have been employed in chromatography for both the purification of proteins [20]
and in various forms of chromatographic binding assays [19].
A molecularly imprinted polymer (MIP) is another type of binding
agent that can be used as an alternative to antibodies [21–25]. A MIP
is a synthetic polymer that is prepared to have recognition sites for
a given target. This type of material is produced through a polymerization reaction which makes use of one or more functional monomers, a cross-linking agent and a template, with the latter being the
target of interest or a compound that is related in structure to the
target [21–23]. A common scheme for preparing a MIP, or for ‘molecular imprinting,’ is shown in Figure 2. During this procedure, the
functional monomers are allowed to interact with complementary regions on the template. These monomers are then set in place by reacting them with a cross-linking agent. The result is a highly ordered
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Figure 2. An example of a procedure for the creation of a MIP against a given target [21–23]. MIP: Molecularly imprinted polymer.

polymer that contains cavities and functional groups that are complementary to the size, shape and structure of the template. The template is then removed, leaving behind a specific binding site that can
later be used to extract or retain the same template or desired target
from a sample [21–24]. Although MIPs are based on a polymeric network rather than a biological agent, it has been found that MIPs can
be generated with specificities and affinities that are similar to those
of antibodies [25]. These features have made MIPs of interest as binding agents in biosensors, traditional immunoassays and extractions
[21–25], as well as in some types of chromatographic methods [21,25].
Detection methods in chromatographic immunoassays
Chromatographic immunoassays can be used with a variety of detection methods. Common examples are absorbance and fluorescence
detection, with chemiluminescence, electrochemical detection, radiometric detection, thermal measurements and MS also having been
employed [7,8,10]. Many of these detection methods require the use
of an antibody or target analog that contains a chemical label or
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enzymatic tag. However, some of these methods make use of the inherent properties of the target for its direct detection [7,10].
This latter situation often occurs in the case of absorbance detection. This method works best for targets that can absorb light in the
UV or visible range and that have moderate or relatively high concentrations in the sample. Typical detection limits for this approach are
in the 10-8 to 10-7 M range when used for direct target detection, with
some applications even reaching levels of 10-9 M [8]. Lower detection
limits can also be obtained with absorbance detection when this is
combined with enzyme labels that can generate products which will
absorb UV or visible light [8,10,12].
Fluorescence detection can be used with analytes that are naturally fluorescent or with analogs of these targets that contain a fluorescent tag. Examples of fluorescent tags that have been used in chromatographic immunoassays are fluorescein, Texas red, Cascade blue
and Lucifer yellow [8]. A major advantage of fluorescence over absorbance is that it is capable of providing much more selective detection
and lower detection limits. The limit of detection when using traditional fluorescent tags on a target or labeled compound is often in
the range of 10-9 to 10-11 M [7,8]. Even lower detection limits are again
possible when fluorescence detection is combined with an enzyme
label [8]. Near infrared fluorescent tags have also been employed in
chromatographic immunoassays [26–28], resulting in detection limits as low as 10-10 to 10-13 M [26,27].
Two other detection methods that usually require the use of a label
are those based on chemiluminescence or radioisotopes. Chemiluminescence makes use of a label or reagent that is capable of producing light as a result of a chemical reaction [7,8,29,30]. Two examples of
chemiluminescent tags are acridinium ester and derivatives of luminol
[8]. Advantages of this detection method are the low background response and ease with which small amounts of light can be measured,
which can provide detection limits down to 10-12 to 10-13 M [7,29,30].
Radiolabels such as iodine-125 have been used for detection in a few
chromatographic immunoassays for targets such as methotrexate and
2,4-dinitrophenol, with detection limits ranging from 10-7 to 10-9 M
[8,31]. However, this detection approach has several potential disadvantages. These disadvantages include safety issues that are associated with the handling of radiolabels and the limited stability of radiolabels over extended periods of time [8,10].
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MS, thermometric analysis and electrochemical detection have
also been employed in chromatographic immunoassays. MS has been
combined with both on-line and off-line chromatographic immunoassays and has been used for the analysis of a variety of targets [6,9,32].
Thermometric detection has been used with enzyme labels to measure the heat that is produced by an enzymatic reaction [7,8]. The limits of detection that have been obtained in chromatographic immunoassays based on thermometric detection have ranged from 10-8 to
10-10 M [7,8,33]. Electrochemical detection has been used with enzyme
labels and chromatographic immunoassays to measure the change
in current that occurs upon the oxidation or reduction reaction of an
electrochemically active product. This combination has provided limits of detection ranging from 10-7 to 10-11 M [7,8].
In chromatographic immunoassays that use enzyme labels, the enzyme tag is combined with a substrate to produce an enzymatic product, which is then measured [8,10]. A major advantage of using an enzyme label is its ability to act as a catalyst and produce many copies
of the product, which results in signal amplification [8]. The enzymes
that are most often utilized as labels in chromatographic immunoassays are β-galactosidase, alkaline phosphatase and horseradish peroxidase. Other enzymes that have been used in these assays are catalase, glucose oxidase and adenosine deaminase. The products of
these enzymes have been measured through the use of light absorption, fluorescence, chemiluminescence, electrochemical detection and
thermometric analysis [8].
Liposomes have also been employed as labels in chromatographic
immunoassays [7,8]. In this case, the liposome label is composed of
phospholipids that have been coupled with either an antibody or
antigen; the liposome also contains many copies of a water soluble
marker (e.g., a fluorescent compound). During the detection phase
of the chromatographic immunoassay, the structure of the liposome
is disrupted through the addition of a detergent or by using shear
force to release markers within the liposome for detection. This process can lead to a large signal, as each liposome may contain up to
103 copies of the marker compound. Liposome labels have been used
in chromatographic immunoassays for the detection of various targets, such as caffeine, theophylline, antitheophylline, imazethapyr and
17-estradiol [8].
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Supports, immobilization methods & elution conditions
Another important component of a chromatographic immunoassay is the support that contains the immobilized antibody or antibody-related agent. The type of support that is used will be determined by the overall goal of the assay. For example, supports that are
to be employed in offline or manual methods and that do not require
high efficiency are often based on large and relatively nonrigid materials such as agarose or cellulose. Other supports that are sometimes
used in these methods are organic polymers such as polyacrylamide,
polymethacrylate, polyethersulfone and related derivatives [6,7]. These
materials are often inexpensive and easy to use at low back pressures;
however, they tend to have slow mass transfer properties and can be
difficult to use in automated systems, such as those utilized in HPLC.
Most of these materials are used in packed columns for chromatographic immunoassays [6–8,10,13], but it is also possible to use lowperformance supports to carry out chromatographic immunoassays
in planar systems, as occurs in lateral flow immunoassays [19]. A typical system for this latter method is shown in Figure 3A. Nitrocellulose
is a common support that is employed in these planar methods [19].
Supports are also available for chromatographic immunoassays
that can be used in HPLC systems. An example of such a system is
provided in Figure 3B. The supports that are used in these systems
are often more expensive, smaller in size and have greater mechanical
stability than those that are used in low-performance or planar systems. Examples of supports that can be used with HPLC include small
diameter silica or porous glass beads, perfusion supports and some
types of monolithic materials [6–8]. The advantages of using these
materials with HPLC to carry out chromatographic immunoassays include the ease with which such systems can be automated, the ability to couple these methods on-line with other analytical techniques
(e.g., MS or other forms of HPLC), and the speed and precision of the
resulting assays [6–8,10,12,13].
The method of attachment for the immobilized agent in a chromatographic immunoassay is another important factor to consider
[6,8]. This process often involves covalent immobilization. This type
of immobilization can be conducted by reacting free amine groups
on an antibody or related binding agent with a support that has been
activated with chemicals such as N,N’-carbonyl diimidazole, cyanogen
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Figure 3. Examples of chromatographic immunoassays using low- or high-performance supports. (A) General scheme for the use of a chromatographic immunoassay in a planar system, such as a lateral flow immunoassay [19] and (B) an example of an HPLC system for conducting a chromatographic sandwich immunoassay,
as based on the use of a postcolumn reactor for chemiluminescent detection. The
system in (B) is based on a method that was reported in [29].

bromide, N-hydroxy succinimide or tresyl chloride/tosyl chloride
[6,8,34,35]. Activated supports with oxidized functional groups, such
as aldehydes or epoxy groups, can also be utilized to immobilize these
binding agents through their free amine groups [6,7]. In an alternative approach, carbohydrate groups found in the Fc regions of antibodies can be oxidized and used for the site directed immobilization
of antibodies onto supports that contain hydrazide or amine groups
[34,35]. In addition, Fab fragments can be coupled through their free
sulfhydryl groups with thiol-reactive supports [6,34,35].
Antibodies or binding agents such as aptamers can also be immobilized through the use of secondary binding agents [6,7,19]. For instance, this may involve the biotinylation of antibodies or aptamers,
followed by the biospecific coupling of these agents to supports that
contain immobilized streptavidin or avidin [19,35]. Another option
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for antibodies is to adsorb them to supports that contain immobilized immunoglobulin binding agents such as protein A or protein G.
These latter agents bind to the Fc regions in many types of antibodies
and can allow for the site-specific but reversible coupling of an antibody to a chromatographic support [6–8,13,35]. If desired, the adsorbed antibodies can later be released from the protein A or protein
G by lowering the pH of the mobile phase. The protein A or G support can then be regenerated prior to the application of a fresh portion of antibodies [7,10,13].
The application of a sample or assay components in a chromatographic immunoassay is usually conducted through the use of a buffer that allows for strong and efficient binding. In most cases, physiological conditions (e.g., a pH of 7.0–7.4) are utilized to allow optimum
binding to occur between the antibody or binding agent and its target [6–8]. Typical elution conditions that are used to later dissociate
an antibody from its target might involve lowering the pH of the mobile phase or changing the composition of this mobile phase, such as
through the addition of a chaotropic agent (e.g., thiocyanate, trifluoroacetate, iodide or chloride) [6–8,12]. If the support or column is to
be used for multiple assays, as is usually the case in HPLC based applications, care must be taken to select elution conditions that do not
cause irreversible damage to the immobilized antibodies or binding
agents within the column [6,36]. It is also necessary in this situation
to allow sufficient time for the column to regenerate prior to application of the next sample [36].
Chromatographic immunoassays with direct target detection
For some types of targets and samples it is possible to use chromatographic immunoassays with a ‘nonlabel’ format and direct detection of the target [6–8]. This type of direct detection chromatographic immunoassay is usually carried out by using step or gradient
elution, as is represented in Figure 1 [6,7,11]. In this method, a sample is first applied to a column containing immobilized antibodies
or related agents that can bind to some components in the sample.
This application is carried out under conditions in which the column
can selectively retain its target, while other components of the sample tend to wash through the column. An elution buffer is later used
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to release the target from the column for its detection or for use in
a second analytical method. Once the target has been removed, the
column may then be regenerated before the application of the next
sample [6–8,10].
The specificity and response of a chromatographic immunoassay
with direct detection will depend on the nature of the target and its
interaction with the immobilized antibodies or binding agents [8].
In this format, it is usually desirable to have relatively strong binding
of the target with the immobilized binding agents so that this compound can be effectively retained by the column during the sample
application step. However, it should also be possible to later release
the target, such as by changing the pH, polarity or composition of
the buffer that is passing through the column [6,8]. The immobilized binding agents should also be sufficiently selective for the target to avoid giving a response that might be due to other sample
components [7,8].
The relative response of a chromatographic immunoassay with direct detection will tend to increase as the amount of target in the sample increases [7,8,10,37,38]. One factor that will determine the usable
range of this response is the amount of active binding agent that is
present in the column [8]. For instance, as the amount of the applied
target is increased, the binding sites in the column will eventually become saturated and will no longer provide a change in response as
the amount of the target is increased further. The application flow rate
can also affect this response, where low flow rates will tend to provide a better capture efficiency and lower detection limit for the target, while higher flow rates will give a lower capture efficiency but a
broader dynamic range [8]. Another interesting feature for this type of
assay is that the response is generally dependent on the moles of the
applied target rather than on its initial concentration [8,37]. A practical consequence of this feature is that adjustments can be made to
the volume of sample that is applied to the column in order to adjust
the calibration range for the target to lower concentration-based limits of detection. This effect has been demonstrated with a multicolumn chromatographic immunoassay system for atrazine and its degradation products, where an increase in the applied sample volume
from 0.4 to 3.0 ml resulted in a steeper slope for the calibration plot
and a decrease in the concentration- based detection limit of atrazine
from 170 to 20 ng/l [37].
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There have been several reports that have made use of direct detection in chromatographic immunoassays. These applications have
utilized detection based on light absorption, fluorescence, chemiluminescence or MS [7,10,38–47]. This method has been used for large
targets such as proteins, peptides and carbohydrates [7]. For instance,
one report utilized this format in a dual-column HPLC system for the
simultaneous analysis of human serum albumin (HSA) and IgG in serum [38]. Other applications have utilized the direct detection format in clinical tests for bacteria such as Escherichia coli and methicillin-resistant Staphylococcus aureus [39,40]. This format has also
been employed for the analysis of various low mass targets, including drugs, herbicides, toxins and synthetic dyes [7,9,41–45]. A recent
report used chemiluminescent detection to directly measure bovine
serum albumin that had been selectively adsorbed to columns packed
with molecularly imprinted microspheres [46]. A related system has
been utilized with magnetic oil-based surface molecularly imprinted
nanoparticles for the analysis of bisphenol A [47].
Although the use of direct detection in a chromatographic immunoassay has the advantages of speed and simplicity, there are several possible disadvantages for this format. First, the target must have
some inherent signal that can be measured (e.g., absorbance or fluorescence), and the target needs to be present in a sample at a concentration that will provide a measurable signal [8,10]. This requirement
tends to limit the use of direct detection in chromatographic immunoassays to major sample components or those with moderate concentrations. As a result, this method is usually not suitable for trace
analysis unless it is used with large sample volumes [8,37]. In these situations, an alternative would be to use a chromatographic immunoassay based on indirect detection (e.g., a competitive binding immunoassay or immunometric assay), as will be discussed later in this review.
Another way to enhance the capabilities of a chromatographic immunoassay with direct detection is to couple this format with other
analytical techniques. When immobilized antibodies are used to isolate a target prior to its measurement or analysis by a second method,
this approach is often referred to as immunoextraction [7,8]. This may
be carried out by using columns that are prepared in-house, or by using one of the growing number of columns that are available commercially for this type of work [48–52]. In many cases, the column that
is used for immunoextraction can be placed on-line with the second
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analysis method, as has been used with various forms of HPLC, MS
and CE [8,9,12,32]. Analytical methods can also be combined off-line
with immunoextraction, as is commonly used in coupling this technique with GC or GC–MS [7]. For instance, the results in Figure 1B
were obtained by using the off-line immunoextraction of d-methamphetamine to aid in the measurement of this drug in urine by GC–
MS [14]. A related approach to immunoextraction is ‘immunodepletion,’ in which an immobilized antibody column is used to selectively
extract major components from a sample (e.g., major proteins), while
other components (e.g., trace proteins) are allowed to pass through
the column for further analysis [7,53].
There are many examples of hybrid methods that have made use
of immunoextraction [7–10,12,13]. For instance, immmunoextraction
has been coupled with LC–MS for the measurement of S-methamphetamine in urine [45]. Immunoextraction columns have been used
off-line with ultra-high performance LC (UHPLC) and MS/MS for the
determination of aflatoxin M1 in ice cream [49], and immunoaffinity columns were utilized off-line with LC–MS/MS for the analysis of
multiple mycotoxins in food [50,51]. In addition, immunoextraction
has been coupled both on-line and off-line with HPLC and fluorescence detection for the measurement of aflatoxins and mycotoxins
in food [48,52,54], and used off-line with HPLC for the measurement
of phenylethanolamine in animal feed and meat or liver samples [55].
Immobilized antibody fragments have been used to analyze the enantiomers of diarylalkyltriazole [56], and an immunoaffinity column
has been used to separate ginsenoside epimers [57]. A chromatographic immunoassay with direct detection was combined with reversed-phase LC for measuring the free fractions of warfarin enantiomers in mixtures of this drug with HSA [58]. Immunoextraction has
also been coupled with biointeraction analysis, as has been used to
isolate and examine the binding of in vivo glycated HSA with sulfonylurea drugs [59].
Several applications have been reported for MIPs in the extraction
of target compounds prior to their analysis by a second method. Examples include approaches that have been developed for the analysis
of various herbicides and drugs in serum, urine, food or tissue samples [21,25]. A nano-sized MIP was prepared with multiple templates
and used to extract various metabolites of polycyclic aromatic hydrocarbons from urine, followed by the separation and measurement of
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these compounds by UHPLC with fluorescence detection [60]. Microspheres based on MIPs were created and used for isolating clenbuterol and other β-agonists from pork tissue, followed by their analysis using UHPLC coupled with MS/MS [61].
Competitive binding chromatographic immunoassays
A second group of chromatographic immunoassays are those that
employ a competitive binding format. These methods are based on
the indirect detection of a target through its competition with a labeled analog of the target (known as the ‘label’) for sites that are available in a column containing an antibody or related binding agent
[8,10]. There are various types of competitive binding chromatographic immunoassays. The three most common approaches are the
simultaneous injection method, the sequential injection method and
the displacement immunoassay [7,8,10].
Simultaneous injection methods
The simultaneous injection method is a type of competitive binding chromatographic immunoassay in which a sample is mixed with
a fixed amount of the label and both are applied together to a column containing a limited amount of an immobilized antibody or related binding agent for the target (see Figure 4) [7,8,62,63]. The target
and label compete for this binding agent as the sample/label mixture is passed through the column. Once the nonretained portion of
the mixture has been washed from the column, an elution buffer can
be used to release the captured target and label. The amount of label that elutes either in the nonretained fraction or the retained peak
can then be used for the indirect measurement of the amount of target that was in the original sample [7,8].
The response of this method is dependent on many factors. These
factors include the moles of label that are combined with the sample,
the moles of the immobilized binding agent that are present, the injection flow rate and the adsorption kinetics of the column [8,62]. It
is also important to use a label which can produce a signal that will
not be significantly affected by the presence of the sample matrix, if
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Figure 4. Chromatographic competitive binding immunoassay. (A) General scheme
for a chromatographic-based competitive binding immunoassay using the simultaneous injection format and (B) a calibration curve obtained for gentamicin in this
type of assay based on fluorescence detection and a 10 cm × 3 mm id antibody column. The labeled target analog, or ‘label,’ in (A) is represented by the stars and the
target is represented by the hexagons. The plots in (B) were obtained from a set of
two trials that were conducted after the initial development of the column (circles)
and after 2 months (triangles). (B) Adapted with permission from [66].

the nonretained fraction is measured, or the elution buffer, if the retained fraction is used for the analysis [8]. The lowest detection limits in this method tend to occur at low-to-moderate flow rates and
when using columns where the amount of active binding sites is in the
same general range as the moles of target that are to be detected in
the samples [8,62,63]. The fact that a labeled target analog is used in
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this method generally provides simultaneous injection methods with
lower detection limits than can be obtained with chromatographic immunoassays that employ direct target detection [8].
The simultaneous injection method has been used to measure
many compounds, including both low and high mass targets, in
complex samples [7,8,62–66]. This format has been used with absorbance measurements or fluorescent tags for the determination
of proteins such as transferrin, IgG and HSA [8,62,63]. Other reports
have used the simultaneous injection method with fluorescent labels for analysis of the hormones testosterone, adrenocorticotropic
hormone and cortisol [7,8]. This method has been employed for the
measurement of cephalexin in milk [64], and the measurement of
atrazine in water and citrus fruits [65]. The simultaneous injection
method has also been used with a fluorescent label for measuring
gentamicin in serum, as is illustrated in Figure 4B. In this last example, results were obtained within 10 min, and the assay gave good
agreement with an HPLC reference method [66]. A variation of the
simultaneous injection method was reported for the analysis of Hg2+,
in which an immobilized analog of the target (i.e., a protein–Hg2+
conjugate) was combined with both samples and antibodies that
could bind to this metal ion [67].
Sequential injection methods
The sequential injection method is similar to the simultaneous injection method but has the sample being applied first to a column
containing an immobilized antibody or related binding agent, followed later by application of the label [8,68]. The amount of label that
elutes in either the nonretained or retained fractions is again used as
an indirect measure of the amount of target that was in the sample
[8]. The use of separate steps for the injection of the sample and label allows the target to have the first opportunity to bind to the immobilized binding agent; this feature tends to result in lower limits of
detection than can be obtained with the simultaneous injection format [62]. The use of separate application steps also creates a situation in which the label is never in contact with the sample. This approach helps to minimize or eliminate any effects the sample matrix
may have on the measurement of the label [7,8,68].
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Many of the same factors that affect the response of the simultaneous injection format affect the sequential injection method. For
instance, the moles of the label and binding agent are important, in
addition to the flow rate that is used for injection and the adsorption kinetics within the column [8,68]. The best limits of detection
again tend to occur at low-to-moderate flow rates, but separate flow
rates can now be utilized for the application of the sample and label [68]. Another difference between the simultaneous and sequential injection methods is in the effect of varying the amount of the
label. In the simultaneous injection method, changing the amount
of the label can have a relatively large effect on the limit of detection [8,62,63], while this effect is not as large in the sequential injection method [62,68].
There have been many applications of the sequential injection
method for measuring drugs, proteins and other targets [8,62,68–
72]. For instance, nonlabeled HSA was used as both the target and ‘label’ in an HPLC based sequential injection method that could measure
this protein in samples in less than 10 min [68]. This general approach
was used with an enzyme label and an antibody capillary column to
measure hyaluronan in serum as a potential biomarker for liver disease and cancer [68]. The sequential injection method has also been
utilized in bioprocess monitoring for the analysis of proteins such as
IgG and HSA [8]. This method has been used with liposome labels and
fluorescence detection for the measurement of IgE in serum [71]. It
has further been employed with a label based on liposome-encapsulated quantum dots in a multiplex assay for a variety of sulfonamides
and quinoline residues in milk [72].
Displacement immunoassays
A displacement immunoassay is another form of a competitive
binding chromatographic immunoassay [7,8,73]. In the most common
format for this approach (see Figure 5), the label is first applied to a
column containing an immobilized antibody or related agent and allowed to occupy most or all of the binding sites in the column. The
excess label is then washed away and the sample is injected. As the
sample passes through the column, the target can bind to any sites
that are momentarily unoccupied by the label. This competition results
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Figure 5. Chromatographic displacement immunoassay. (A) General scheme for a
chromatographic-based displacement immunoassay and (B) a typical chromatogram obtained by this method for thyroxine (T4) when using acridinium ester-labeled
triiodothyronine (AE-T3, which was the ‘label’ in this method) and anti-T4 antibodies
that were adsorbed to a 10 mm × 2.1 mm id protein G column. The labeled target
analog, or ‘label,’ in (A) is represented by the stars and the target is represented by
the hexagons. In (B), the antibodies and label were combined and applied simultaneously to the protein G column; the displacement peak was monitored through
the use of a postcolumn reactor to detect the chemiluminescence of the label. (B)
Reproduced with permission from [30].

in the displacement of some label and produces a peak for the displaced label that is related to the amount of target that was in the
sample [7,8].
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There are several potential advantages to this approach when
compared with other types of competitive binding immunoassays. First, the response due to the displaced label increases as the
amount of the target is increased, and often does so in a linear
manner at low-to-moderate target concentrations [7,8]. Second, the
displacement peak often appears with or just after the nonretained
sample components, which can lead to a method with short analysis times [8,27,30]. Third, this method can be utilized for relatively
high throughput measurements, especially if the amount of label
that is present in the column is sufficient for use with multiple sample injections before the column must be regenerated and reloaded
with the label [7,8,27,30,73]. Like the simultaneous and sequential
injection methods, a displacement immunoassay can often be used
to obtain lower limits of detection than can be acquired with chromatographic immunoassays that employ direct detection. The main
disadvantage of all these competitive binding immunoassays when
compared with direct detection is that they require a labeled analog
of the target [7,8].
Several factors can affect the behavior of a displacement assay.
These factors include the amount and type of label that is used, the injection flow rate and the application conditions that are employed for
the label and the sample, the amount of binding agent that is in the
column, and the association/dissociation rates of the binding agent
for the target and label [8]. For instance, the injection flow rate must
be slow enough to provide sufficient time for the target to bind to the
column and displace enough label to give a measurable response. This
method also requires that the label dissociates from the antibodies at
a rate that is neither too fast nor too slow. A fast rate of label dissociation will result in a high signal for the first few sample injections, but
this signal will quickly decrease for later sample injections as the label leaves the column. On the other hand, a slow rate of label dissociation will lead to broad displacement peaks that may be difficult to
detect [8]. Another consideration is the binding constant for the label with the immobilized antibodies or binding agents. Best displacement results tend to be obtained when the label has a binding constant that is not as strong as it is for the target [8,30].
A variety of applications have been reported for displacement
immunoassays [7,27,30,74,75]. One recent application has been
the use of this format in combination with ultrafast immunoaffinity
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extraction for the analysis of free drug or free hormone fractions in
serum or in mixtures of these agents with transport proteins [27,30].
An example of such an application, which was combined with chemiluminescent detection to measure the free fraction of thyroxine in
serum, is illustrated in Figure 5B. This technique gave a result within
30 s of sample injection and had a detection limit of 6 pM [30]. Displacement immunoassays have also been used to detect drugs such
as cocaine or benzoylecgonine and targets such as coumaphos or
ochratoxins [7,74,75].
Immunometric assays
Chromatographic immunoassays can also be carried out by using
various immunometric formats [7,8,10–12]. These methods are noncompetitive immunoassays that utilize indirect detection and a labeled antibody or labeled binding agent to measure a target [5]. The
two primary formats for these assays, when used in chromatographic
systems, are sandwich immunoassays (i.e., two-site immunometric assays) and one-site immunometric assays [7,8].
Sandwich immunoassays
A chromatographic sandwich immunoassay employs two types of
antibodies or related binding agents that can bind simultaneously to
the same target [3,8,10]. Figure 6 shows one way in which this type of
assay can be carried out in a chromatographic system. In this example, one type of antibody or binding agent is immobilized to a support and placed within the column. The other antibody/binding agent
is labeled and mixed with the sample before both of these components are applied to the column or applied to the column after the
sample has been injected [29]. The result is the formation of a sandwich complex in which the target is bound to both a labeled binding
agent and an immobilized binding agent. The retained target and its
associated labeled binding agent can later be eluted from the column.
The amount of retained labeled binding agent is then measured and
used to provide a response that is related to the amount of target that
was in the original sample. If desired, the column or support may then
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Figure 6. Chromatographic sandwich immunoassay. (A) General scheme for a chromatographic-based sandwich immunoassay and (B) a set of chromatograms obtained for the detection of PTH in plasma by using a 20 mm × 4 mm id column containing immobilized antibodies that could bind to one region of PTH, along with
soluble acridinium ester-labeled antibodies against a different region of PTH to form
a sandwich complex with this target. The tag on the soluble and labeled antibodies in (A) is represented by the stars and the target is represented by the hexagons.
A postcolumn reactor was used in (B) to detect the chemiluminescence of the labeled antibodies that were retained by the column; sample injections were made
every 6 min, as indicated by the arrows. Both the response due to the nonretained
sample components, as measured at 280 nm, and the chemiluminescent response
measured for samples containing (from left-to-right) 0, 25, 50 or 75 pM PTH are
shown in (B). PTH: Parathyroid hormone. (B) Adapted with permission from [29].

Matsuda et al. in Bioanalysis 7 (2015)

24

be regenerated and used for the next application of the sample and
labeled binding agent [8,10].
One advantage of using a chromatographic sandwich immunoassay, especially when compared with simultaneous and sequential injection competitive binding immunoassays, is that it can give a linear
response over a relatively broad range of target concentrations [8].
This response, plus the selectivity that is provided by using two types
of binding agents for the same target, can result in better selectivity
and lower limits of detection than can usually be obtained in competitive binding assays or direct detection methods [3,7,8,12]. A limitation
of sandwich immunoassays is that they can only be used with relatively high mass targets such as proteins, large peptides or other macromolecules that can interact with two antibodies/binding agents simultaneously. The need for two types of binding agents can also make
this approach more expensive than a competitive binding assay [8].
Several types of targets have been examined by using chromatographic-based sandwich immunoassays [7,8]. For instance, chromatographic sandwich immunoassays using chemiluminescent tags
or enzyme labels have been developed for human and mouse IgG
[7,8,76,77]. Related methods using fluorescence or amperometric detection have been utilized for the measurement of HSA [7,78].
A system based on this format has been developed for analysis of
parathyroid hormone in plasma by using chemiluminescent labeled
antibodies, with results being obtained within 6 min of sample injection [29], as shown in Figure 6B. Another method combined chemiluminescent detection with traditional antibodies or nanobodies that
were attached to magnetic beads and silica nanoparticles for use in
flow-based sandwich immunoassays that could measure microcystinLR or prealbumin [79,80]. Other chromatographic sandwich immunoassays have been described for IL-5, anti-HCV antibodies, potato
virus X, cardiac troponin and myoglobin [81–84]. Sandwich immunoassays have also been applied to the determination of allergens, bacteria and toxins in food [85–89].
Chromatographic sandwich immunoassays have been developed
for other applications. This type of assay was utilized for examining a lipopolysaccharide antigen and cells of Brucella abortus [90].
A method for measuring hepatitis B virus surface antigen in serum
was created by using a chromatographic sandwich immunoassay with
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fluorescence detection [91]. A test strip utilizing this general approach
was developed for the detection of rabies in canine serum [92]. Quantum dots were employed in a sandwich immunoassay format for the
analysis of C-reactive protein [93], and chromatographic sandwich immunoassays have been made for detecting lily mottle virus and lily
symptomless virus [94,95]. In addition, sandwich immunoassays in a
chromatographic format have been employed with gold nanoparticle labels for the diagnosis of malaria and for the detection of S. aureus [96,97]. Aptamers have also been utilized in sandwich immunoassays on planar supports [98–100]. For instance, a flow-based sensor
for thrombin was created that used immobilized aptamers and aptamers that were conjugated to gold nanoparticles for detection [98].
Similar approaches using aptamers have been reported for Ramos
cells [99] and E. coli [100].
One-site immunometric assays
One-site immunometric assays can also be carried out in a chromatographic format [8]. This method first involves the incubation of
a sample containing the target with an excess of labeled antibodies,
or related binding agents like antibody fragments that can bind this
target (see Figure 7). This mixture is then injected onto a column that
contains an immobilized analog of the target. The target and its complex with the labeled antibody/binding agent will tend to pass through
the column, while the immobilized analog will capture any excess of
the labeled binding agent that is still present. The size of the nonretained peak due to the complex of the target with the labeled agent
provides a response that is related to the amount of target that was
in the sample. An elution buffer can later be passed through the column to release the captured and labeled binding agent; the size of
this retained peak can also be used to determine how much target
was present in the sample. If desired, the column can be regenerated
before making another series of injections of the target and labeled
binding agent [101,102].
A linear increase in response over a relatively broad range of target levels can be obtained when using the nonretained peak due to
the labeled binding agent and its complex with the target [8,102].
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Figure 7. Chromatographic one-site immunometric assay. (A) General scheme for
a chromatographic-based onesite immunometric assay and (B) calibration plots
obtained in this method by using anti-HSA antibodies that were labeled with a NIR
fluorescent tag and injected with samples onto a 5 mm × 2.1 mm id microcolumn
containing immobilized HSA. The tag on the soluble and labeled antibodies in (A)
is represented by the stars, the target is represented by the hexagons in solution
and the immobilized target analog is represented by the hexagons at the surface
of the support. The error bars in (B) represent a range of ± 1 standard error of the
mean (n = 3). HSA: Human serum albumin; NIR: Near-infrared. (B) Reproduced
with permission from [26].
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Alternatively, a decrease in response with the target’s concentration is
seen if the retained fraction of the labeled binding agent is used [8].
The response of this method will be affected by the amount of the labeled binding agent that is combined with the sample, the time that is
allowed for the incubation step, the binding capacity of the immobilized analog column and the capture efficiency of the column for the
labeled binding agent [8,102]. One advantage of this method when
compared with other chromatographic immunoassays is that if the
column binding capacity is sufficiently high, multiple sample/labeled
binding agent mixtures can be injected between elution/regeneration
cycles. Another advantage of using an immobilized analog column is
that elution conditions can be used that may not be feasible in techniques that instead employ immobilized antibodies or antibody fragments (e.g., competitive binding immunoassays or sandwich immunoassays) [8,102]. The main limitation of this format is the need for a
different immobilized analog column for each target or group of targets that are to be analyzed [8].
One-site immunometric assays have been described for drugs, hormones, proteins and other targets [26,101– 106]. An example is provided in Figure 7B, in which this format was used with affinity microcolumns and fluorescence or near-infrared fluorescence detection for
the trace analysis of a protein (HSA), giving results within 35 s to 2.8
min of sample injection [26]. This format has also been used with fluorescence detection for the analysis of granulocyte-colony stimulating factor, modified with poly(ethylene glycol), in rat serum [103] and
IL-10 in cell media [104]. This approach has been utilized with enzyme
labels to detect digoxin or digoxigenin [105], with chemiluminescence
detection for the measurement of thyroxine [102], and with a liposome label to monitor 17-beta-estradiol [106]. Several of these methods have further been used in postcolumn reactors for the detection
of targets as they are separated by other chromatographic methods,
such as reversed-phase LC [7,101,103].
Conclusion
This review examined the general principles of chromatographic
immunoassays and the use of these methods for the analysis of drugs,
biological compounds and other targets in complex samples. The
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main components of a chromatographic immunoassay were discussed, including the types of binding agents, detection methods
and supports that have been used in these techniques. The various
formats that can be used in a chromatographic immunoassay were
then examined. This included a brief discussion of the advantages or
limitations of each method and the factors that affect their response.
Recent research and developments in this area were discussed, and a
variety of applications for chromatographic immunoassays were presented. These applications ranged from small targets such as drugs,
hormones and environmental agents to larger targets such as peptides, proteins, viral particles, bacteria and cells.
Future perspective
The current field of chromatographic immunoassays already encompasses a relatively broad range of assay formats and applications.
It is expected that the types of components that can be used in these
methods and the formats in which they can be employed will continue to undergo development. One possible area of future research
is in the types of binding agents that can be used in chromatographic
immunoassays and related methods. This is expected to include the
more extensive use of aptamers [17–20] and MIPs [21–25,46,47] as alternatives to antibodies. It is also anticipated that there will be more
applications in chromatographic immunoassays that make use of
binding agents such as bispecific antibodies, single-chain antibody
fragments and ‘nanobodies’ [6,16,80,107]. The use of other synthetic
mimics of antibodies (or ‘synbodies’) [108] is another area for possible growth in this field.
Other work that is expected to continue in chromatographic immunoassays is in the types of detection methods, supports and assay
formats that can be used in these techniques. For example, the use
of nanomaterials, such as gold or silver nanoparticles, and quantum
dots should continue to lead to new or enhanced detection methods and formats for these methods [19,85–88,93– 100,109]. The utilization of alternative supports, such as affinity monoliths, is also
expected to continue [110–116]. In addition, further research is anticipated in the development of miniaturized chromatographic immunoassays that can be employed in microfluidic devices and portable
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or disposable devices [19,26–28,30,82–88,100,113,116]. These developments, in turn, should increase the range of applications for
which chromatographic immunoassays can be used in areas that include clinical chemistry, pharmaceutical testing, drug development
and biomedical research [7,8].
Executive summary
Background
• Chromatographic immunoassays use an antibody or related binding agent as
part of a chromatographic system for the isolation or measurement of a specific target.
General components of chromatographic immunoassays
• Polyclonal or monoclonal antibodies are often used in these methods, along
with antibody fragments; other binding agents that have been employed include autoantibodies, anti-idiotypic antibodies, genetically engineered antibodies or antibody fragments, aptamers and molecularly imprinted polymers.
• A wide range of detection methods have been used in chromatographic immunoassays, such as absorbance or fluorescence detection, chemiluminescence,
electrochemical detection, radiometric detection, thermal measurements and
MS, as well as methods that use enzymes or liposomes as labels.
• Various support materials and immobilization schemes can be used in chromatographic immunoassays, along with formats based on columns or planar supports.
Chromatographic immunoassays with direct target detection
• Some chromatographic immunoassays can be used for the direct detection of a
target, as may involve detection based on light absorption, fluorescence, chemiluminescence or MS.
• It is also possible to use the immunoextraction of a target prior to its measurement or analysis by a second method, such as HPLC, ultra-high performance
LC, LC–MS or LC–MS/MS.
Competitive binding chromatographic immunoassays
• Competitive binding immunoassays can be carried out in a chromatographic
immunoassay by using simultaneous or sequential injection of the sample and
a labeled analog of the target.
• A displacement immunoassay format is another form of a competitive binding
immunoassay that can be carried out in a flow-based system.
Immunometric assays
• Labeled antibodies or binding agents can also be used in chromatographic immunoassays, resulting in methods that are known as immunometric assays.
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• The two common forms of chromatographic-based immunometric assays are
sandwich immunoassays and one-site immunometric assays.
Conclusion
• Chromatographic immunoassays have been used for the selective analysis of
drugs, hormones, peptides, proteins and other agents in areas that include
clinical chemistry, pharmaceutical analysis, biomedical research and food
testing.

Financial & competing interests disclosures: Some of the methods described in
this review are the subjects of US Patents 6,720,193 and 6,727,104. Part of the work
described in this review was supported by the NIH under grants R01 GM044931
and R01 DK069629 and by the National Science Foundation/EPSCoR program under grant EPS-1004094. D Suresh was supported by the University Grants Commission in India though a Raman Postdoctoral Fellowship. The authors have no other
relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed
in the manuscript apart from those disclosed. No writing assistance was utilized in
the production of this manuscript.

References
Papers of special note have been highlighted as: • of interest
1 Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics (7th Edition).
Burtis CA, Bruns ED (Eds). Saunders, MO, USA (2015).
2 Contemporary Practice in Clinical Chemistry (2nd Edition). Clarke WA (Ed.). AACC
Press, Washington, DC, USA (2011).
3 The Immunoassay Handbook: Theory and Applications of Ligand Binding, ELISA
and Related Techniques (4th Edition). Wild D (Ed.). Elsevier, Amsterdam, The
Netherlands (2013).

4 Darwish IA. Immunoassay methods and their applications in pharmaceutical
analysis: basic methodology and recent advances. Int. J. Biomed. Sci. 2, 217–235
(2006).
5 Hage DS. Immunoassay. Anal. Chem. 71, R294–R304 (1999).

6 Hage DS, Phillips TM. Immunoaffinity chromatography. In: Handbook of Affinity
Chromatography (2nd Edition). Hage DS (Ed.). Taylor and Francis, NY, USA, 127–
172 (2006).
7 Moser AC, Hage DS. Immunoaffinity chromatography: an introduction to
applications and recent development. Bioanalysis 4, 769–790 (2010).

8 Moser AC, Hage DS. Chromatographic immunoassays. In: Handbook of Affinity
Chromatography (2nd Edition). Hage DS (Ed.). Taylor and Francis, NY, USA, 789–
836 (2006).

Matsuda et al. in Bioanalysis 7 (2015)

31

• Provides a detailed discussion of the practical considerations and theory for
various types of chromatographic immunoassays.

9 Delaunay-Bertoncini N, Hennion MC. Immunoaffinity solid-phase extraction
for pharmaceutical and biomedical trace analysis-coupling with HPLC and CE
perspectives. J. Pharm. Biomed. Anal. 34, 717–736 (2004).

10 Hage DS, Nelson MA. Chromatographic immunoassays. Anal. Chem. 73, A198–
A205 (2001).
11 Weller MG. Immunochromatographic techniques – a critical review. Fresenius J.
Anal. Chem. 366, 635–645 (2000).
12 Jackson AJ, Sobansky MR, Hage DS. Principles and applications of
immunoaffinity chromatography. In: Antibodies. Meulenberg EP (Ed.). Bentham,
The Netherlands (2012).
13 de Frutos M, Regnier FE. Tandem chromatographicimmunological analyses.
Anal. Chem. 65, A17–A25 (1993).

• Discusses various approaches for combining chromatographic immunoassays
and immunoaffinity chromatography with other forms of chromatography.

14 Lua AC, Chou TY. Preparation of immunoaffinity columns for direct
enantiomeric separation of amphetamine and/or methamphetamine. J.
Chromatogr. A 967, 191–199 (2002).

15 Kobayashi N, Oyama H. Antibody engineering toward high-sensitivity highthroughput immunosensing of small molecules. Analyst 136, 642–651 (2011).
16 Arnold-Schild D, Kleist C, Welschof M et al. One-step single-chain Fv
recombinant antibody-based purification of gp96 for vaccine development.
Cancer Res. 60, 4175–4178 (2000).

17 Iliuk AB, Hu L, Tao WA. Aptamers in bioanalytical applications. Anal. Chem. 83,
4440–4452 (2011).
18 Mascini M (Ed.). Aptamers in Bioanalysis. Wiley, NJ, USA (2009).

19 Chen A, Yang S. Replacing antibodies with aptamers in lateral flow
immunoassays. Biosens. Bioelectron. 83, 230–242 (2015).

• Discusses how aptamers have been used in chromatographic immunoassays
based on planar supports.

20 Ahiwar R, Nahar P. Development of an aptamer-affinity chromatography for
efficient single step purification of Concanavalin A from Canavalia ensiformis. J.
Chromatogr. B Analyt. Technol. Biomed. Life Sci. 997, 105–109 (2015).
21 Haupt K. Molecularly imprinted polymers: artificial receptors for separation. In:
Handbook of Affinity Chromatography (2nd Edition). Hage DS (Ed.). Taylor and
Francis, NY, USA, 837–856 (2006).
• Provides an overview on the principles and applications of molecularly
imprinted polymers.

22 Ruigrok VJB, Levisson M, Eppink MHM et al. Alternative affinity tools: more
attractive than antibodies? Biochem. J. 436, 1–13 (2011).

23 Komiyama M, Takeuchi T, Mukawa T, Asanuma H. Molecular Imprinting from
Fundamentals to Applications. Wiley-VCH, Weinheim, Germany (2002).

Matsuda et al. in Bioanalysis 7 (2015)

32

24 Zhang H. Water-compatible molecularly imprinted polymers: promising
synthetic substitutes for biological receptors. Polymer 55, 699–714 (2014).

25 Fodey T, Leonard P, O’Mahoney J et al. Developments in the production of
biological and synthetic binders for immunoassay and sensor-based detection
of small molecules. Trends Anal. Chem. 30, 254–269 (2011).

26 Pfaunmiller EL, Anguizola JA, Milanuk ML et al. Development of microcolumnbased one-site immunometric assays for protein biomarkers. J. Chromatogr. A
1366, 92–100 (2014).
• Describes a recent example of a one-site immunometric assay.

27 Ohnmacht CM, Schiel JE, Hage DS. Analysis of free drug fractions using near
infrared fluorescent labels and an ultrafast immunoextraction/displacement
assay. Anal. Chem. 78, 7547–7556 (2006).

28 Schiel JE, Tong Z, Sakulthaew C, Hage DS. Development of a flow-based
ultrafast immunoextraction and reverse displacement immunoassay: analysis of
free drug fractions. Anal. Chem. 83, 9384–9390 (2011).
29 Hage DS, Kao PC. High-performance immunoaffinity chromatography and
chemiluminescent detection in the automation of a parathyroid hormone
sandwich immunoassay. Anal. Chem. 63, 586–595 (1991).
• Discusses various factors that are important in the development of a
chromatographic-based sandwich immunoassay.

30 Clarke W, Schiel JE, Moser A, Hage DS. Analysis of free hormone fractions by
an ultrafast immunoextraction/ displacement immunoassay: studies using free
thyroxine as a model system. Anal. Chem. 77, 1859–1866 (2005).
31 Kusterbeck AW, Wernhoff GA, Charles PT et al. A continuous flow
immunoassay for rapid and sensitive detection of small molecules. J. Immunol.
Methods 135, 191–197 (1990).
32 Briscoe CJ, Clarke W, Hage DS. Affinity mass spectrometry. In: Handbook of
Affinity Chromatography (2nd Edition). Hage DS (Ed.). Taylor and Francis, NY,
USA, 737–761 (2006).
33 Mecklenburg M, Lindbladh C, Li H et al. Enzymic amplification of a flowinjected thermometric enzymelinked immunoassay for human insulin. Anal.
Biochem. 212, 388–393 (1993).
34 Kim HS, Hage DS. Immobilization methods for affinity chromatography. In:
Handbook of Affinity Chromatography (2nd Edition). Hage DS (Ed.). Taylor &
Francis, NY, USA, 35–78 (2006).

35 Hermanson GT. Bioconjugate Techniques (3rd Edition). Academic Press, NY, USA
(2013).
36 Hage DS, Xuan H, Nelson MA. Application and elution in affinity
chromatography. In: Handbook of Affinity Chromatography (2nd Edition). Hage
DS (Ed.). Taylor & Francis, NY, USA, 79–97 (2006).
37 Rollag JG, Beck-Westermeyer M, Hage DS. Analysis of pesticide degradation
products by tandem high-performance immunoaffinity chromatography and
reversed-phase liquid chromatography. Anal. Chem. 68, 3631–3637 (1996).
38 Hage DS, Walters RR. Dual-column determination of albumin and

Matsuda et al. in Bioanalysis 7 (2015)

33

immunoglobulin G in serum by highperformance affinity chromatography. J.
Chromatogr. 386, 37–49 (1987).

39 Bouvrette P, Luong JHT. Development of a flow injection analysis (FIA)
immunosensor for the detection of Esherichia coli. Int. J. Food. Mircobiol. 27,
129–137 (1995).

40 Shin KS, Song HG, Kim K et al. Direct detection of methicillin-resistant
Staphylococcus aureus from blood cultures using an immunochromatographic
immunoassaybased MRSA rapid kit for the detection of penicillin-binding
protein 2a. Diagn. Microbiol. Infect. Dis. 67, 301–303 (2010).
41 Delaunay-Bertoncini N, Pichon V, Hennion MC. Comparison of
immunoextraction sorbents prepared from monoclonal and polyclonal antiisoproturon antibodies and optimization of the appropriate monoclonal
antibodybased sorbent for environemtnal and biological applications.
Chromatographia 53, S224–S230 (2001).

42 Hage DS, Papastavros E, Snow DD. High-performance immunosorbents for the
selective trace analysis of emerging contaminants in water. Proc. Water Environ.
Fed.2010 meeting, 5794–5806 (2011).
43 Pfaunmiller E, Moser AC, Hage DS. Biointeraction analysis of immobilized
antibodies and related agents by highperformance immunoaffinity
chromatography. Methods 56, 130–135 (2012).

44 Driedger DR, Sporns P. Immunoaffinity sample purification and MALD-TOF
MS analysis of α-solanine and α-chanconine in serum. J. Agric. Food Chem. 49,
543–548 (2001).

45 Lua AC, Sutono Y, Chou TY. Enantiomeric quantification of (S)-(+)methamphetamine in urine by an immunoaffinity column and liquid
chromatography–electrospray-mass spectrometry. Anal. Chim. Acta 576, 50–54
(2006).
• Shows how immunoextraction can be coupled with LC–MS for the analysis of
biological samples.

46 Jinghua Y, Fuwei W, Congcong Z et al. Molecularly imprinted polymeric
microspheres for determination of bovine serum albumin based on flow
injection chemiluminescence sensor. Biosens. Bioelectron. 26, 632–637 (2010).
47 Cao W, Chao Y, Liu L et al. Flow injection chemiluminescence sensor based
on magnetic oilbased surface molecularly imprinted nanoparticles for
determination of bisphenol A. Sens. Actuators B Chem. 204, 704–709 (2014).

48 Zuo Z, Liu G, Chen Y, Cheng J. Assessment of aflatoxins in pigmented rice using
a validated immunoaffinity column method with fluorescence HPLC. J. Food
Compost. Anal. 31, 252–258 (2013).
49 Ossa DEH, Hincapie DA, Penuela GA. Determination of aflatoxin M1 in ice
cream samples using immunoaffinity columns and ultra-high performance
liquid chromatography coupled to tandem mass spectrometry. Food Control
56, 34–40 (2015).

50 Wilcox J, Donnelly C, Leeman D, Marley E. The use of immunoaffinity columns
connected in tandem for selective and cost-effective mycotoxin clean-up

Matsuda et al. in Bioanalysis 7 (2015)

34

prior to multi-mycotoxin liquid chromatographic-tandem mass spectrometric
analysis in food matrices. J. Chromatogr. A 1400, 91–97 (2015).

51 Desmarchelier A, Tessiot S, Bessaire T et al. Combining the quick, easy, cheap,
effective, rugged and safe approach and clean-up by immunoaffinity column
for the analysis of 15 mycotoxins by isotope dilution liquid chromatography
tandem mass spectrometry. J. Chromatogr. A 1337, 75–84 (2014).

52 Zhao X, Yuan Y, Zhang X, Yue T. Identification of ochratoxin A in Chinese spices
using HPLC fluorescent detectors with immunoaffinity column cleanup. Food
Control 46, 332–337 (2014).
53 Mortezai N, Wagener C, Buck F. Combining lectin affinity chromatography and
immunodepletion – a novel method for the enrichment of disease-specific
glycoproteins in human plasma. Methods 56, 254–259 (2012).
54 Jinap S, De Rijk TC, Arzandeh S et al. Aflatoxin determination using in-line
immunoaffinity chromatography in foods. Food Control 26, 42–48 (2012).

55 Mei L, Cao B, Yang H et al. Development of an immunoaffinity chromatography
column for selective extraction of a new agonist phenylethylamine A from
feed, meat and liver samples. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.
945–946, 178–184 (2014)
56 Nevanen TK, Soderholm L, Kukkonen K et al. Efficient enantioselective
separation of drug enantiomers by immobilised antibody fragments. J.
Chromatogr. A 925, 89–97 (2001).

57 Qu H, Wang Y, Shan W et al. Development of ELISA for detection of Rh1 and
Rg2 and potential method of immunoaffinity chromatography for separation
of epimers. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 985, 197–205
(2015).
58 Clarke W, Chowdhuri AR, Hage DS. Analysis of free drug fractions by using
ultrafast immunoaffinity chromatography. Anal. Chem. 73 2157–2164 (2001).

59 Anguizola J, Joseph KS, Barnaby OS et al. Development of affinity
microcolumns for drug-protein binding studies in personalized medicine:
interactions of sulfonylurea drugs with in vivo glycated human serum albumin.
Anal. Chem. 85, 4453–4460 (2013).

60 Chauhan A, Bhatia T, Singh A et al. Application of nanosized multi-template
imprinted polymer for simultaneous extraction of polycyclic aromatic
hydrocarbon metabolites in urine samples followed by ultra-high performance
liquid chromatographic analysis. J. Chromatogr. B Analyt. Technol. Biomed. Life
Sci. 985, 110–118 (2015).
61 Wang P, Lui X, Su X, Zhu R. Sensitive detection of β-agonists in pork
tissue with novel molecularly imprinted polymer extraction followed liquid
chromatography coupled tandem mass spectrometry detection. Food Chem.
184, 72–79 (2015).
62 Nelson MA, Reiter WS, Hage DS. Chromatographic competitive binding
immunoassays: a comparison of the sequential and simultaneous injection
methods. Biomed. Chromatogr. 17, 188–200 (2003).

• Provides a detailed comparison of the sequential and simultaneous injection
methods for chromatographic-based competitive binding immunoassays.

Matsuda et al. in Bioanalysis 7 (2015)

35

63 Hage DS, Thomas DH, Chowdhuri AR, Clarke W. Development of a theoretical
model for chromatographicbased competitive binding immunoassays with
simultaneous injection of sample and label. Anal. Chem. 71, 2965–2975
(1999).
64 Meyer U, Zhi ZL, Meusel M et al. Automated stand-alone flow injection
immunoanalysis system for the determination of cephalexnin in milk. Analyst
124, 1605–1610 (1999).
65 Turiel E, Fernandez P, Perez-Conde C et al. Flow-through fluorescence
immunosensor for atrazine determination. Talanta 47, 1255–1261 (1998).

66 Yang HH, Zhu QZ, Qu HY et al. Flow injection fluorescence immunoassay for
gentamicin using sol-gelderived mesoporous biomaterial. Anal. Biochem. 308,
71–76 (2002).
67 Xu M, Chen M, Dong T et al. Flow injection chemiluminescence immunoassay
based on resin beads, enzymatic amplification and a novel monoclonal
antibody for determination of Hg2+. Analyst 140, 6373–6378 (2015).
68 Hage DS, Thomas DS, Beck MS. Theory of a sequential addition competitive
binding immunoassay based on highperformance immunoaffinity
chromatography. Anal. Chem. 65, 1622–1630 (1993).

69 Lee M, Durst RA, Wong RB. Comparison of liposome amplification and
fluorophor detection in flow-injection immunoanalyses. Anal. Chim. Acta 354,
23–28 (1997).

70 Kradtrap Hartwell S, Boonmalai A, Kongtawelert P, Grudpan K. Sequential
Injection-immunoassay system with a plain glass capillary reactor for the assay
of hyaluronan. Anal. Sci. 26, 69–74 (2010).
71 Ho JA, Wu LC, Chang LH et al. Liposome-based immunoaffinity
chromatographic assay for the quantitation of immunoglobulin E in human
serum. J. Chromatogr. B 878, 172–176 (2010).

72 Jiang W, Beloglazova NV, Wang Z et al. Development of a multiplex flowthrough immunoaffinity chromatography test for the on-site screening of 14
sulfonamide and 13 quinoline residues in mild. Biosens. Bioelectron. 66, 124–
128 (2015).
73 Proll G, Ehni M. Immunoassays. In: Handbook of Spectroscopy (2nd Edition).
Gauglitz G, Moore DS (Eds.). Wiley-VCH Verlag, Weinheim, Germany (2014).
74 Dai Z, Liu H, Shen Y et al. Attomolar determination of coumaphos by
electrochemical displacement immunoassay coupled with oligonucleotide
sensing. Anal. Chem. 84, 8157–8163 (2012).
• Provides a recent example of a displacement immunoassay.

75 Lates V, Yang C, Popescu IC. Displacement immunoassay for the detection of
ochratoxin A using ochratoxin B modified glass beads. Anal. Bioanal. Chem.
402, 2861–2870 (2012).
76 Johns MA, Rosengarten LK, Jackson M, Regnier FE. Enzyme-linked
immunosorbent assays in a chromatographic format. J. Chromatogr. A 743,
195–206 (1996).

77 Wang Q, Wang Y, Luo G, Yeung WSB. Feasibility study of enzyme-amplified
sandwich immunoassay using protein G capillary affinity chromatography and

Matsuda et al. in Bioanalysis 7 (2015)

36

laser induced fluorescence detection. J. Liq. Chromatogr. Relat. Technol. 24,
1953–1963 (2001).

78 Yoshikawa T, Terashima M, Katoh S. Immunoassay using HPLAC and
fluorescence-labeled antibodies. J. Ferment. Bioeng. 80, 200–203 (1995).

79 Lu J, Wei W, Yin L et al. Flow injection chemiluminescence immunoassay
of microcystin-LR by using PEI-modified magnetic beads as capturer and
HRPfunctionalized silica nanoparticles as signal amplifier. Analyst 138, 1483–
1489 (2013).
80 Ma L, Sun Y, Kang X, Wan Y. Development of nanobodybased flow injection
chemiluminescence immunoassay for sensitive detection of human
prealbumin. Biosens. Bioelectron. 61, 165–171 (2014).

81 Hayes MA, Polson NA, Phayre AN, Garcia AA. Flowbased microimmunoassay.
Anal. Chem. 73, 5896–5902 (2001)

82 Xiang T, Jiang Z, Zheng J et al. A novel double antibody sandwich-lateral flow
immunoassay for the rapid and simple detection of hepatitis C virus. Int. J. Mol.
Med. 30, 1041–1047 (2012).
83 Safenkova I, Zherdev A, Dzantiev B. Factors influencing the detection limit of
the lateral-flow sandwich immunoassay: a case study with potato virus X. Anal.
Bioanal. Chem. 403, 1595–1605 (2012).
84 Zhu J, Zou N, Zhu D et al. Simultaneous detection of high-sensitivity cardiac
troponin I and myoglobin by modified sandwich lateral flow immunoassay:
proof of principle. Clin. Chem. 57, 1732–1738 (2011).
85 Wang Y, Deng R, Zhang G et al. Rapid and sensitive detection of the food
allergen glycinin in powdered milk using a lateral flow colloidal gold
immunoassay strip test. J. Agric. Food Chem. 63, 2172–2178 (2015).

86 Gao S, Nie C, Wang J et al. Colloidal gold-based immunochromatographic test
strip for rapid detection of abrin in food samples. J. Food Prot. 75, 112–117
(2012).
87 Yang W, Li XB, Liu GW et al. A colloidal gold probebased silver enhancement
immunochromatographic assay for the rapid detection of abrin-a. Biosens.
Bioelectron. 26, 3710–3713 (2011).
88 Niu K, Zheng X, Huang C et al. A colloidal gold nanoparticle-based
immunochromatographic test strip for rapid and convenient detection of
Staphylococcus aureus. J. Nanosci. Nanotechnol. 14, 5151–5156 (2014).

89 Cho YJ, Lee DH, Kim DO et al. Production of a monoclonal antibody against
ochratoxin A and its application to immunochromatographic assay. J. Agric.
Food Chem. 53, 8447–8451 (2005).

90 Byzova NA, Zherdev AV, Eskendirova SZ et al. Development of
immunochromatographic test system for the rapid detection of
lipopolysaccharide antigen and cells of causative agent of bovine brucellosis.
Prikl. Biokhim. Mikrobiol. 48, 653–661 (2012).

91 Shen J, Zhou Y, Fu F et al. Immunochromatographic assay for quantitative and
sensitive detection of hepatitis B virus surface antigen using highly luminescent
quantum dotbeads. Talanta 142, 145–149 (2015).

Matsuda et al. in Bioanalysis 7 (2015)

37

92 Tao C, Li G. A rapid one-step immunochromatographic test strip for rabies
detection using canine serum samples. Lett. Appl. Microbiol. 59, 247–251
(2014).

93 Cheng X, Pu X, Jun P et al. Rapid and quantitative detection of C-reactive
protein using quantum dots and immunochromatographic test strips. Int. J.
Nanomedicine 9, 5619–5626 (2014).

94 Zhang Y, Wang Y, Yang W et al. A rapid immunochromatographic test to detect
the lily mottle virus. J. Virol. Methods 220, 43–48 (2015).

95 Zhang Y, Wang Y, Meng J et al. Development of an immunochromatographic
strip test for rapid detection of lily symptomless virus. J. Virol. Methods 220, 13–
17 (2015).
96 Wu J, Peng Y, Liu X et al. Evaluation of Wondfo rapid diagnostic kit
(Pf-HRP2/PAN-pLDH) for diagnosis of malaria by using nano-gold
immunochromatographic assay. Acta Parasitol. 59, 267–271 (2014).

97 Huang SH. Gold nanoparticle-based immunochromatographic test for
identification of Staphylococcus aureus from clinical specimens. Clin. Chim. Acta
373, 139–143 (2006).
98 Xu H, Mao X, Zeng Q, Wang S, Kawde AN, Liu G. Aptamer-functionalized gold
nanoparticles as probes in a dry-reagent strip biosensor for protein analysis.
Anal. Chem. 81, 669–675 (2009).

99 Liu G, Mao X, Phillips JA, Xu H, Tan W, Zeng L. Aptamernanoparticle strip
biosensor for sensitive detection of cancer cells. Anal. Chem. 81, 10013–10018
(2009).

100 Bruno JG. Application of DNA aptamers and quantum dots to lateral flow test
strips for detection of foodborne pathogens with improved sensitivity versus
colloidal gold. Pathogens 3, 341–355 (2014).
101 Irth H, Oosterkamp AJ, Tjaden UR, van der Greef J. Strategies for on-line
coupling of immunoassays to highperformance liquid chromatography.
Trends Anal. Chem. 14, 355–361 (1995).

102 Oates MR, Clarke W, Zimlich A, Hage DS. Optimization and development of
a high-performance liquid chromatography-based one-site immunometric
assay with chemiluminescence detection. Anal. Chim. Acta 470, 37–50 (2002).
103 Miller KJ, Herman AC. Affinity chromatography with immunochemical
detection applied to the analysis of human methionyl granulocyte colony
stimulating factor in serum. Anal. Chem. 68, 3077–3082 (1996).

104 Kjellstrom S, Emneus J, Marko-Varga G. Flow immunochemical biorecognition detection for the determination of interleukin-10 in cell samples.
J. Immunol. Methods 246, 119–130 (2000).

105 Lindgren A, Emneus J, Marko-Varga G et al. Optimisation of a heterogeneous
non-competitive flow immunoassay comparing fluorescein, peroxidase and
alkaline phosphatase as labels. J. Immunol. Methods 211, 33–42 (1998).
106 Locascio-Brown L, Choquette SJ. Measuring estrogens using flow injection
immunoanalysis with liposome amplification. Talanta 40, 1899–1904 (1993).
107 Fridy PC, Li Y, Keegan S. A robust pipeline for rapid production of versatile

Matsuda et al. in Bioanalysis 7 (2015)

38

nanobody repertoires. Nat. Methods 11, 1253–1260 (2014).

108 Dienhnelt CW, Shah M, Gupta N et al. Discovery of highaffinity protein
binding ligands – backwards. PLoS ONE 5, e10728, (2010).

109 Lochner N, Lobamaier C, Wirth M et al. Silver nanoparticles enhanced
immunoassays: one step real time kinetic assay for insulin in serum. Eur. J.
Pharm. Biopharm. 56, 469–477 (2003).
110 Pfaunmiller EL, Paulemond ML, Dupper CM, Hage DS. Affinity monolith
chromatography: a review of principles and recent analytical applications.
Anal. Bioanal. Chem. 405, 2133–2145 (2013).
111 Tetala KKR, Van Beek TA. Bioaffinity chromatography and monolithic
supports. J. Sep. Sci. 33, 422–438 (2010).

112 Yoo MJ, Hage DS. Affinity monolith chromatography: principles and recent
developments. In: Monolithic Chromatography and its Modern Applications.
Wang P (Ed.). ILM Publications, St Albans, UK (2010).

113 Jiang T, Mallik R, Hage DS. Affinity monoliths for ultrafast immunoextraction.
Anal. Chem. 77, 2362–2372 (2005).
114 Mallik R, Hage DS. Affinity monolith chromatography. J. Sep. Sci. 29, 1686–
1704 (2006).

115 Li L, Wang J, Zhou S, Zhao M. Development and characterization of an
immunoaffinity monolith for selective on-line extraction of bisphenol A from
environmental water samples. Anal. Chim. Acta 620, 1–7 (2008).
116 LeGac S, Carlier J, Carmart JC et al. Monoliths for microfluidic devices in
proteomics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 808, 3–14
(2004).

